A 'polypill' aimed at preventing cardiovascular disease could prove highly cost-effective for use in Latin America.
Bautista LE, Vera-Cala LM, Ferrante D, Herrera VM, Miranda JJ, Pichardo R, Sánchez Abanto JR, Ferreccio C, Silva E, Oróstegui Arenas M, Chirinos JA, Medina-Lezama J, Pérez CM, Schapochnik N, Casas JP.
Bautista LE, et al.
Health Aff (Millwood). 2013 Jan;32(1):155-64. doi: 10.1377/hlthaff.2011.0948.
Health Aff (Millwood). 2013.
PMID: 23297283